Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium
NCT ID: NCT01623050
Last Updated: 2014-11-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
36 participants
INTERVENTIONAL
2012-04-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study
NCT02463279
Clinical Evaluation of the Steroid-Eluting Sinexus Intranasal Splint When Used Following Functional Endoscopic Sinus Surgery (FESS) in Patients With Chronic Sinusitis
NCT00912405
A Clinical Evaluation of the Sinexus Intranasal Splint Following Functional Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis
NCT00840970
Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia
NCT02228720
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
NCT01525849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SinuSys Dilation System
Maxillary Sinus Dilation
SinuSys Dilation System
Sinuplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SinuSys Dilation System
Sinuplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Sinonasal tumours
* Cystic fibrosis
* History of facial trauma that distorts sinus anatomy and precludes access to the maxillary sinus
* Pregnant or breastfeeding females
* Currently participating in another drug or device study
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SinuSys Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Catalano, MD
Role: PRINCIPAL_INVESTIGATOR
St Elizabeth Medical Center
Amin Javer, MD
Role: PRINCIPAL_INVESTIGATOR
St. Paul's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Valley ENT
Tucson, Arizona, United States
Palo Alto Medical Foundation
Palo Alto, California, United States
St. Elizabeth Medical Center
Boston, Massachusetts, United States
St. Paul's Hospital, ENT Department
Vancouver, British Columbia, Canada
Charing Cross Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNS-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.